Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Artiva Biotherapeutics, Inc.ARTV · Entity 5404 | Director | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Artiva Biotherapeutics, Inc.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.42 · Expires 2036-09-09 | Direct | 16,250 |
Reported balance
After 2026-09-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-10 · Grant · Acquired 16,250 · Balance 16,250 F1: The shares subject to the option will vest in full on the earlier of September 10, 2027, or the date of the Issuer's 2027 annual stockholder meeting. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest in full on the earlier of September 10, 2027, or the date of the Issuer's 2027 annual stockholder meeting.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BRISTOL MYERS SQUIBB CO
Report date July 01, 2014 · Filed July 02, 2014
Section 16 reporting ended · disclosed 2014-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.10 par valueSEC Table I · non-derivative | Direct | 94,374.041 |
Ending reported balance
After 2014-07-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2014-07-01 · Exercise / conversion · Acquired 4,671 · Balance 96,477.041 Row 2 · 2014-07-01 · Tax withholding · Disposed 2,103 · Balance 94,374.041 F1: Shares withheld for payment of taxes upon vesting of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,340 |
Reported balance
After 2014-07-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2014-07-01 · Exercise / conversion · Disposed 4,671 · Balance 9,340 F2: Each restricted stock unit converts into one share of common stock upon vesting. F3: Represents vesting of one-third of restricted stock units granted on July 1, 2011. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of taxes upon vesting of restricted stock units.
F2: Each restricted stock unit converts into one share of common stock upon vesting.
F3: Represents vesting of one-third of restricted stock units granted on July 1, 2011.
Cabaletta Bio, Inc.
Report date June 01, 2021 · Filed June 28, 2021 · Amendment
Section 16 reporting ended · disclosed 2021-06-28. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.00 · Expires 2031-05-31 | Direct | 0 |
Reported balance
After 2021-06-01 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2021-06-01 · Grant · Disposed 22,000 · Balance 0 F1: This option shall vest in accordance with the following schedule: (1) 25% of the shares subject to the option shall vest on June 24, 2022 and (2) the remaining 75% of the shares subject to the option shall vest in equal quarterly installments over the next 3 years, subject to the Reporting Person's continued service relationship with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: This option shall vest in accordance with the following schedule: (1) 25% of the shares subject to the option shall vest on June 24, 2022 and (2) the remaining 75% of the shares subject to the option shall vest in equal quarterly installments over the next 3 years, subject to the Reporting Person's continued service relationship with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2011 Filed May 10, 2011 14:14 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 20,880 | $28.77 | $600,717.60 |
DisclosureSEC source: 0001225208-11-013673 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,567 Read SEC document |
| May 01, 2011 Filed May 2, 2011 20:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,236 | $28.10 | $34,731.60 |
DisclosureSEC source: 0001225208-11-012775 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,447 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. Read SEC document |
| March 06, 2011 Filed Mar 8, 2011 22:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,367 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-009156 · doc4.xml · derivative · entry 6 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,366 Underlying: Common Stock, $0.10 par value · 2,367 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F6 · derivative.exercise_date: Shares consist of restricted stock units that vest 25% on each of the first, second, third and fourth anniversaries of the grant date and are converted into shares of common stock. F6 · derivative.expiration_date: Shares consist of restricted stock units that vest 25% on each of the first, second, third and fourth anniversaries of the grant date and are converted into shares of common stock. Read SEC document |
| March 06, 2011 Filed Mar 8, 2011 22:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,081 | $26.43 | $28,570.83 |
DisclosureSEC source: 0001225208-11-009156 · doc4.xml · nonDerivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,683 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2011 Filed Mar 8, 2011 22:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-009156 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares acquired upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 22:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 1,870 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-009156 · doc4.xml · derivative · entry 5 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,740 Underlying: Common Stock, $0.10 par value · 1,870 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F5 · derivative.exercise_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date. F5 · derivative.expiration_date: Shares consist of restricted stock units with one-third vesting on each of the third, forth, and fifth anniversaries of the grant date. Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 22:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 680 | $26.43 | $17,972.40 |
DisclosureSEC source: 0001225208-11-009156 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,397 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 04, 2011 Filed Mar 8, 2011 22:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 1,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-009156 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares acquired upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 02, 2011 Filed Mar 5, 2011 00:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionMarket Share Units · Derivative | 3,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008890 · doc4.xml · derivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,249 Underlying: Common Stock, $0.10 par value · 3,812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company's common stock on the vesting date and the nine trading days immediately preceding the vesting date. F6 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor. F6 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor. Read SEC document |
| March 02, 2011 Filed Mar 5, 2011 00:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008890 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,207 F4 · shares: Shares withheld for payment of taxes upon vesting of market share units. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| March 02, 2011 Filed Mar 5, 2011 00:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherCommon Stock, $0.10 par value | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008890 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,644 F3 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| March 02, 2011 Filed Mar 5, 2011 00:47 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 3,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008890 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares acquired upon vesting of market share units. F2 · balance_after: Includes unvested restricted stock units. Read SEC document |
| March 02, 2011 Filed Mar 16, 2011 20:34 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,437 | $25.39 | $36,485.43 |
DisclosureSEC source: 0001225208-11-009872 · doc4a.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,207 F4 · shares: This Form 4 is amended to report the correct price for the shares withheld for payment of taxes upon vesting of market share units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 32,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · derivative · entry 9 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,643.77 Underlying: Common Stock, $0.10 par value · 32,822 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F1 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F6 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F6 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | OtherPerformance Shares · Derivative | 465.77 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · derivative · entry 8 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,465.77 Underlying: Common Stock, $0.10 par value · 465.77 shares Expires not disclosed F11 · derivative.exercise_price: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013. F11 · shares: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013. F11 · derivative.exercise_date: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013. F11 · derivative.expiration_date: Shares represent dividend equivalents earned under the 2010-2012 regular performance share unit award and will convert into one share of common stock upon payout in the first quarter of 2013. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 8,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · derivative · entry 7 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock, $0.10 par value · 8,545 shares Expires not disclosed F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F10 · shares: Consists of performance shares earned under the 2009-2011 Long-Term Performance Award. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 9,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · derivative · entry 6 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,455 Underlying: Common Stock, $0.10 par value · 9,115 shares Expires not disclosed F7 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F8 · shares: Consists of performance shares earned under the 2010-2012 Long-Term Performance Award. F7 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. F7 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 9,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · derivative · entry 5 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,340 Underlying: Common Stock, $0.10 par value · 9,882 shares Expires not disclosed F6 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F1 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F6 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F6 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 14,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · derivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,061 Underlying: Common Stock, $0.10 par value · 14,811 shares Expires not disclosed F4 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company's common stock on the vesting date and the nine trading days immediately preceding the vesting date. F5 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor. F5 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a performance factor. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 6,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,692 F3 · shares: Shares withheld for payment of taxes upon payout of the 2008-2010 special long-term performance award. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 5,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,333 F2 · shares: Shares withheld for payment of taxes upon payout of the 2008-2010 regular long-term performance award. Read SEC document |
| March 01, 2011 Filed Mar 4, 2011 11:00 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 32,822 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-008709 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. Read SEC document |
| March 01, 2011 Filed Mar 16, 2011 20:34 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 6,641 | $25.58 | $169,876.78 |
DisclosureSEC source: 0001225208-11-009872 · doc4a.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,692 F3 · shares: This Form 4 is amended to report the correct price for the shares withheld for payment of taxes upon payout of the 2008-2010 special long-term performance award. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2011 Filed Mar 16, 2011 20:34 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 5,293 | $25.58 | $135,394.94 |
DisclosureSEC source: 0001225208-11-009872 · doc4a.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,333 F1 · shares: This Form 4 is amended to report the correct price for the shares withheld for payment of taxes upon payout of the 2008-2010 regular long-term performance award. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 01, 2010 Filed May 4, 2010 16:54 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 1,037 | $24.93 | $25,852.41 |
DisclosureSEC source: 0001225208-10-011789 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,804 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. Read SEC document |
| March 17, 2010 Filed Mar 18, 2010 13:31 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 6,800 | $25.89 | $176,052.00 |
DisclosureSEC source: 0001225208-10-008506 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,841 F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 07, 2010 Filed Mar 10, 2010 01:30 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 523 | $24.60 | $12,865.80 |
DisclosureSEC source: 0001225208-10-007601 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,641 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2010 Filed Mar 10, 2010 01:30 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,366 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007601 · doc4.xml · derivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,707 Underlying: Common Stock, $0.10 par value · 2,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F5 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F5 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 06, 2010 Filed Mar 10, 2010 01:30 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 861 | $24.60 | $21,180.60 |
DisclosureSEC source: 0001225208-10-007601 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,164 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2010 Filed Mar 10, 2010 01:30 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007601 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2010 Filed Dec 29, 2011 17:27 UTC Amendment | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,366 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-027049 · doc4a.xml · derivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,367 Underlying: Common Stock, $0.10 par value · 2,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F2 · derivative.exercise_date: Twenty-five percent of the restricted stock units will vest on each of the first, second, third, and fourth anniversaries of the grant date and be converted into shares of common stock. F2 · derivative.expiration_date: Twenty-five percent of the restricted stock units will vest on each of the first, second, third, and fourth anniversaries of the grant date and be converted into shares of common stock. F3 · balance_after: This Form 4 is being amended to reflect the correct number of derivative securities beneficially owned following this reported transaction. The number of derivative securities beneficially owned following the transaction reported for this award in a Form 4 filed on March 8, 2011 was also reported incorrectly. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionPerformance Shares · Derivative | 10,774 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007218 · doc4.xml · derivative · entry 7 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,458 Underlying: Common Stock, $0.10 par value · 10,774 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 3,293 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007218 · doc4.xml · derivative · entry 6 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,232 Underlying: Common Stock, $0.10 par value · 3,293 shares Expires not disclosed F9 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. F10 · shares: Consists of performance shares earned under the 2007-2009 Long-Term Performance Award. F9 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. F9 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2010. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 9,518 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007218 · doc4.xml · derivative · entry 5 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,939 Underlying: Common Stock, $0.10 par value · 9,518 shares Expires not disclosed F7 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F8 · shares: Consists of performance shares earned under the 2009-2011 Long-Term Performance Award. F7 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. F7 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2012. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 11,113 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007218 · doc4.xml · derivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,421 Underlying: Common Stock, $0.10 par value · 11,113 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F6 · shares: Consists of performance shares earned under the 2008-2010 Regular Long-Term Performance Award and the 2008-2010 Special Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. F5 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2011. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantMarket Share Units · Derivative | 15,250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007218 · doc4.xml · derivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,250 Underlying: Common Stock, $0.10 par value · 15,250 shares Expires not disclosed F3 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock based on the average of the closing share price of the company?s common stock on the vesting date and the nine trading days immediately preceding the vesting date. F4 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a conversion factor. F4 · derivative.expiration_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date and will be converted into shares of common stock based on a conversion factor. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 3,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007218 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,659 F2 · shares: Withheld for the payment of taxes upon payout of shares under a Long-Term Performance Award. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 23:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 10,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007218 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Consists of shares earned as long-term performance awards under the 2002 Stock Incentive Plan. Read SEC document |
| March 01, 2010 Filed Mar 3, 2010 21:24 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 616 | $24.57 | $15,135.12 |
DisclosureSEC source: 0001225208-10-006833 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,804 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 08, 2009 Filed May 8, 2009 20:34 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | SaleCommon Stock, $0.10 par value | 5,200 | $20.15 | $104,780.00 |
DisclosureSEC source: 0001225208-09-011951 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,420 F1 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| May 01, 2009 Filed May 4, 2009 18:57 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 973 | $19.29 | $18,769.17 |
DisclosureSEC source: 0001225208-09-011320 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,620 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2009 Filed Mar 10, 2009 22:05 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionRestricted Stock Units · Derivative | 2,366 | $18.35 Strike: $0.00 | $43,416.10 |
DisclosureSEC source: 0001225208-09-006766 · doc4.xml · derivative · entry 4 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,733 Underlying: Common Stock, $0.10 par value · 2,366 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The restricted stock units were converted on a one for one basis into shares of common stock upon vesting. F4 · derivative.expiration_date: The restricted stock units were converted on a one for one basis into shares of common stock upon vesting. Read SEC document |
| March 06, 2009 Filed Mar 10, 2009 22:05 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 863 | $18.35 | $15,836.05 |
DisclosureSEC source: 0001225208-09-006766 · doc4.xml · nonDerivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,746 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2009 Filed Mar 10, 2009 22:05 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 524 | $18.35 | $9,615.40 |
DisclosureSEC source: 0001225208-09-006766 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,609 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 06, 2009 Filed Mar 10, 2009 22:05 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Exercise / conversionCommon Stock, $0.10 par value | 2,366 | $18.35 | $43,416.10 |
DisclosureSEC source: 0001225208-09-006766 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:06 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantRestricted Stock Units · Derivative | 8,073 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-006374 · doc4.xml · derivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,073 Underlying: Common Stock, $0.10 par value · 8,073 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock upon vesting. F3 · derivative.exercise_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. F3 · derivative.expiration_date: One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. Read SEC document |
| March 03, 2009 Filed Mar 5, 2009 22:06 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantExecutive Option (right to buy) · Derivative | 95,408 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001225208-09-006374 · doc4.xml · derivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,408 Underlying: Common Stock, $0.10 par value · 95,408 shares Expires 2019-03-02 F1 · derivative.exercise_date: Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Option vests 25% of the shares annually, on a cumulative basis, commencing one year after the date of grant, but may not be exercised until the threshold is satisfied. Read SEC document |
| March 02, 2009 Filed Mar 3, 2009 22:21 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 254 | $17.74 | $4,505.96 |
DisclosureSEC source: 0001225208-09-005830 · doc4.xml · nonDerivative · entry 2 DANIELS BRIAN · CIK 0001428698 · SVP Global Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,767 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| March 01, 2009 Filed Mar 3, 2009 22:21 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | Tax withholdingCommon Stock, $0.10 par value | 633 | $18.41 | $11,653.53 |
DisclosureSEC source: 0001225208-09-005830 · doc4.xml · nonDerivative · entry 1 DANIELS BRIAN · CIK 0001428698 · SVP Global Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,021 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock. F2 · balance_after: Includes unvested restricted stock awards. Read SEC document |
| February 19, 2009 Filed Feb 23, 2009 21:21 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantPerformance Shares · Derivative | 3,830 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-004538 · doc4.xml · derivative · entry 3 DANIELS BRIAN · CIK 0001428698 · SVP Global Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,308 Underlying: Common Stock, $0.10 par value · 3,830 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. F6 · shares: Consists of performance shares earned under the 2007-2009 Long-Term Performance Award. F5 · derivative.exercise_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. F5 · derivative.expiration_date: Each performance share is converted into one share of common stock upon distribution in the first quarter of 2010. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.